NTRK1 and cancer: Large-scale genomic studies have shown that many kinase genes, including those that encode RTKs and non-receptor tyrosine kinases (NRTKs), are recurrently altered in cancer [2], and biological studies have characterised many as bona fide cancer driver genes.